Market Overview - Stock markets are experiencing significant volatility due to the ongoing tariff war, leading to expectations of economic slowdown and rising inflation [1] - The Federal Reserve has kept interest rates unchanged at 4.25-4.5% amid these uncertainties [1] Broker Recommendations - Following brokers' recommendations can simplify stock selection; stocks like Walt Disney Company (DIS), Cognizant Technology (CTSH), and Expand Energy Corporation (EXE) are highlighted as worth buying [2] - Brokers have insights from direct communication with top management and assess publicly available documents, providing a better understanding of company fundamentals and sector performance [3] Stock Selection Strategy - A screening strategy for potential winners includes: - Broker rating upgrades of 1% or more over the last four weeks [5] - Current stock price greater than $5 [5] - Average 20-day trading volume greater than 100,000 [5] - Stocks with a Zacks Rank of 1 (Strong Buy) or 2 (Buy) have a proven record of success, especially when combined with a VGM Score of A or B [6] Company Highlights - **Walt Disney Company (DIS)**: - Expected fiscal 2025 earnings growth of 13.3% year-over-year - Currently holds a Zacks Rank 2 with a 3.5% upward revision in broker ratings over the past four weeks [7] - **Cognizant Technology (CTSH)**: - Projected 2025 earnings growth of 6.5% year-over-year - Currently holds a Zacks Rank 2 with a 4.4% upward revision in broker ratings over the past four weeks [8] - **Expand Energy Corporation (EXE)**: - Expected 2025 earnings growth of 444.7% year-over-year - Currently holds a Zacks Rank 2 with a 7.7% upward revision in broker ratings over the past four weeks [10]

Group 1 - The article compares two stocks in the Computers - IT Services sector: Cognizant (CTSH) and ServiceNow (NOW), focusing on which stock offers better value for investors [1] - Cognizant has a Zacks Rank of 2 (Buy), indicating a positive earnings outlook, while ServiceNow has a Zacks Rank of 3 (Hold) [3] - Value investors typically analyze traditional metrics such as P/E ratio, P/S ratio, earnings yield, and cash flow per share to identify undervalued stocks [4] Group 2 - Cognizant's forward P/E ratio is 15.39, significantly lower than ServiceNow's forward P/E of 59.66, suggesting better value [5] - Cognizant has a PEG ratio of 1.78, while ServiceNow's PEG ratio is 2.52, indicating that Cognizant may offer more value relative to its expected earnings growth [5] - Cognizant's P/B ratio is 2.59 compared to ServiceNow's P/B of 20.08, further supporting Cognizant's superior valuation metrics and its Value grade of B versus ServiceNow's F [6]

Group 1 - ASML is currently outperforming the Computer and Technology sector, with a year-to-date return of approximately 1.1%, while the sector has an average return of -9.1% [4] - The Zacks Rank for ASML is 2 (Buy), indicating a positive outlook based on earnings estimates and revisions, with a consensus estimate for full-year earnings increasing by 8.2% over the past three months [3] - ASML is part of the Semiconductor Equipment - Wafer Fabrication industry, which is ranked 20 in the Zacks Industry Rank and has gained an average of 1% this year, further highlighting ASML's strong performance within its industry [5] Group 2 - Cognizant, another stock in the Computer and Technology sector, has also outperformed the sector with a return of 1.3% year-to-date, and it holds a Zacks Rank of 2 (Buy) [4][5] - The Computers - IT Services industry, to which Cognizant belongs, is ranked 92 and has experienced a decline of -9.1% this year, contrasting with ASML's performance [6]

Core Insights - Cognizant Technology Solutions experienced a positive stock market performance, with shares rising over 2% following a favorable quarterly earnings report [1] - The company's revenue for the first quarter reached approximately $5.12 billion, reflecting a 7.5% increase compared to the same period in 2024 [2] - GAAP net income rose to $663 million from $546 million year-over-year, while non-GAAP earnings per share increased by 10% to $1.23 [2][3] Financial Performance - The revenue growth was supported by a 3% improvement in trailing-12-month bookings, totaling $26.7 billion [2] - Analysts had anticipated lower figures, with expectations of $5.06 billion in revenue and $1.20 per share for adjusted profitability [3] - Cognizant provided guidance for the second quarter and full-year 2025, projecting revenue between $20.5 billion and $21 billion, indicating growth of nearly 4% [4] Strategic Focus - The company highlighted the impact of artificial intelligence (AI) technology on its operations, emphasizing productivity, cost reduction, and resiliency as key areas of focus [4] - The consensus among analysts aligns with Cognizant's guidance, estimating revenue at nearly $20.6 billion and adjusted net income at $4.99 per share [5] - While the quarter was deemed decent, there is a desire for higher growth in bookings to enhance investor confidence [5]

Core Insights - Cognizant Technology Solutions (CTSH) reported non-GAAP earnings of $1.23 per share for Q1 2025, exceeding the Zacks Consensus Estimate by 3.36% and reflecting a year-over-year increase of 9.8% [1] - Revenues reached $5.12 billion, surpassing the consensus mark by 0.95%, with a year-over-year growth of 7.5% and 8.2% at constant currency [1] - The Belcan acquisition contributed approximately 400 basis points to revenue growth, while bookings increased 3% year over year to $26.7 billion, indicating a book-to-bill ratio of about 1.3 times [2] Financial Performance - Financial services revenues, accounting for 28.6% of total revenues, grew 5.6% year over year to $1.462 billion, driven by increased discretionary spending and investments in cloud and AI [4] - Health Sciences revenues, making up 30.7% of total revenues, rose 10.9% year over year to $1.571 billion, supported by strong demand across various sectors [5] - Products and Resources revenues increased 12.8% year over year to $1.27 billion, while Communications, Media and Technology revenues decreased 2.7% to $804 million [5] Regional Performance - North America contributed 75.3% to total revenues, with a year-over-year increase of 9.5% [6] - Revenues from Europe grew 1.2% year over year, contributing 18.6% to total revenues, while the Rest of the World saw a 3.7% increase [6] Operational Metrics - Selling, general & administrative expenses as a percentage of revenues decreased by 60 basis points year over year to 15.5% [7] - The company reported a GAAP operating margin of 16.7%, expanding 210 basis points year over year, and a non-GAAP operating margin of 15.5%, which expanded 40 basis points [8] Balance Sheet Overview - As of March 31, 2025, cash and short-term investments totaled $1.99 billion, down from $2.24 billion at the end of 2024 [9] - Total debt decreased to $600 million from $908 million, while cash generated from operations was $400 million compared to $920 million in the previous quarter [9] Future Guidance - For Q2 2025, revenues are expected to be between $5.14 billion and $5.21 billion, indicating growth of 5.9%-7.4% [10] - For the full year 2025, revenues are projected to be in the range of $20.5-$21 billion, reflecting an increase of 3.9-6.4% [10] - Adjusted earnings per share for 2025 are anticipated to be between $4.98 and $5.14 [11]

Core Insights - Cognizant reported revenue of $5.12 billion for the quarter ended March 2025, reflecting a year-over-year increase of 7.5% and surpassing the Zacks Consensus Estimate by 0.95% [1] - The earnings per share (EPS) for the quarter was $1.23, up from $1.12 in the same quarter last year, exceeding the consensus EPS estimate of $1.19 by 3.36% [1] Financial Performance by Segment - Financial Services revenue was $1.46 billion, exceeding the average estimate of $1.43 billion, with a year-over-year increase of 5.6% [4] - Communications, Media and Technology revenue was $804 million, below the estimated $833.33 million, representing a year-over-year decline of 2.7% [4] - Products and Resources revenue reached $1.28 billion, slightly above the estimated $1.27 billion, with a year-over-year increase of 12.8% [4] - Health Sciences revenue was $1.57 billion, surpassing the average estimate of $1.55 billion, reflecting a year-over-year growth of 11% [4] Stock Performance - Cognizant's shares have returned -4.1% over the past month, compared to a -0.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Group 1 - Cognizant reported quarterly earnings of $1.23 per share, exceeding the Zacks Consensus Estimate of $1.19 per share, and up from $1.12 per share a year ago, representing an earnings surprise of 3.36% [1] - The company achieved revenues of $5.12 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.95%, and an increase from $4.76 billion year-over-year [2] - Cognizant has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Group 2 - The stock has experienced a decline of approximately 4.7% since the beginning of the year, compared to a decline of 5.5% for the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $1.23 on revenues of $5.12 billion, and for the current fiscal year, it is $4.96 on revenues of $20.57 billion [7] - The Computers - IT Services industry, to which Cognizant belongs, is currently ranked in the bottom 39% of over 250 Zacks industries, indicating potential challenges ahead [8]

Financial Performance - Revenues for Q1 2025 increased to $5,115 million, up 7.4% from $4,760 million in Q1 2024[20] - Net income for Q1 2025 was $663 million, representing a 21.4% increase compared to $546 million in Q1 2024[20] - Basic and diluted earnings per share for Q1 2025 were both $1.34, up from $1.10 in Q1 2024[20] - Comprehensive income for Q1 2025 was $794 million, compared to $484 million in Q1 2024[23] - Operating income increased by 22.7% to $853 million in Q1 2025, compared to $695 million in Q1 2024[113] - Adjusted income from operations rose by $73 million or 10.2% from Q1 2024[106] - Operating margin for Q1 2025 improved to 16.7%, up from 14.6% in Q1 2024, driven by net savings from the NextGen program and operational efficiencies[107] - Adjusted diluted EPS increased by 9.8% to $1.23 in Q1 2025, compared to $1.12 in Q1 2024[113] Revenue Breakdown - North America contributed $3,854 million to total revenues in Q1 2025, up from $3,521 million in Q1 2024, reflecting a growth of about 9.5%[36] - The Health Sciences and Financial Services segments contributed positively to revenue growth, while the Products and Resources and Communications, Media and Technology segments showed weakness[107] - Revenue for Q1 2025 increased by $355 million or 7.5% compared to Q1 2024, with an 8.2% increase in constant currency[106] - Recent acquisitions contributed 400 basis points to overall revenue growth, with a significant impact on the Products and Resources segment[117] Cash Flow and Assets - Cash generated from operating activities in Q1 2025 was $400 million, a significant increase of $305 million compared to $95 million in Q1 2024[150] - Total current assets as of March 31, 2025, were $7,545 million, slightly up from $7,504 million at the end of 2024[17] - Cash and cash equivalents at the end of Q1 2025 were $1,980 million, down from $2,231 million at the end of 2024[17] - Long-lived assets as of March 31, 2025, totaled $988 million, slightly down from $994 million as of December 31, 2024[101] Liabilities and Debt - Total liabilities decreased to $5,068 million as of March 31, 2025, down from $5,558 million at the end of 2024[17] - Long-term debt as of March 31, 2025, is $567 million, down from $875 million as of December 31, 2024, reflecting a decrease of 35.2%[52] - The company repaid $300 million of its revolving credit facility during Q1 2025, following a $600 million borrowing in Q3 2024 to fund the acquisition of Belcan[48] Tax and Legal Matters - The effective income tax rate for the three months ended March 31, 2025, is 24.4%, slightly down from 24.8% in the same period of 2024[53] - The company is involved in ongoing disputes with the Indian Tax Department regarding share repurchase transactions valued at $523 million and $2.8 billion from 2013 and 2016, respectively[53] - The ongoing legal proceedings related to Syntel resulted in a reduced damages award from $855 million to $570 million, with further evaluations pending[78] Operational Efficiency - The company reported a decrease in operational costs by H%, improving overall profitability[179] - Voluntary attrition in Tech Services was 15.8% for the trailing twelve months ended March 31, 2025, compared to 13.1% for the same period in 2024[108] Future Outlook and Investments - The company plans to continue significant investments in AI capabilities to meet client needs and enhance internal operations[110] - Market expansion efforts are underway, with plans to enter E new markets by the end of the year[179] - The company is considering strategic acquisitions to enhance its market position, with a budget of $F million earmarked for potential deals[179] Shareholder Returns - Dividends declared in Q1 2025 were $0.31 per share, totaling $154 million[26] - A dividend of $0.31 per share was declared on April 29, 2025, with a record date of May 19, 2025[103] - The company repurchased $190 million of its Class A common stock during Q1 2025, with a remaining balance of $3,047 million authorized for repurchase[173][174]

Financial Data and Key Metrics Changes - First quarter revenue grew by 8.2% year over year in constant currency to $5.1 billion, driven by the Belcan acquisition and organic growth in Health Sciences and Financial Services [6][25] - Adjusted Operating Margin improved by 40 basis points year over year to 15.5%, on track to achieve full year guidance of 20 to 40 basis points of expansion [8][33] - Adjusted EPS grew 10% year over year, marking the sixth consecutive quarter of year over year growth [8][25] Business Line Data and Key Metrics Changes - Health Sciences revenue increased over 11% year over year in constant currency, with broad-based growth across payer, provider, and life sciences [7][28] - Financial Services segment grew 6.5% year over year in constant currency, with healthy discretionary spending as clients invested in cloud and data modernization [7][28] - Products and Resources segment growth was driven by Welch, but faced weak demand due to discretionary spending pressures [29] Market Data and Key Metrics Changes - North America revenue grew 10% year over year in constant currency, driven by Belcan and large deals [30] - Europe revenue increased by 3% year over year in constant currency, supported by life sciences and financial services clients [31] - The Rest of the World saw a 7% year over year increase in constant currency, driven by large deals in Communications, Media, and Technology [32] Company Strategy and Development Direction - The company is investing heavily in AI-powered software-led engineering, integrating expertise in embedded software and IoT with capabilities from recent acquisitions [10][19] - Strategic imperatives include amplifying talent, scaling innovation, and accelerating growth, with a focus on AI and embedded engineering [16][19] - The company aims to build resilience and durability by developing leadership and talent, strengthening operational discipline, and rebooting innovation [9][10] Management's Comments on Operating Environment and Future Outlook - The macro environment changed sharply in early April, leading to elevated uncertainty, but the company sees opportunities related to productivity and efficiency [9][26] - Management remains optimistic about capturing demand in Financial Services and believes the current environment presents opportunities for cost optimization [27] - The company expects revenue growth of 5% to 6.5% year over year in constant currency for the second quarter of 2025 [35][36] Other Important Information - The company had four large deals in the first quarter, including a mega deal valued at over $500 million [8][26] - Free cash flow for the first quarter was $393 million, with plans to redeploy proceeds from the sale of an office complex in India [35] - The company plans to return approximately $1.7 billion to shareholders in 2025, including $1.1 billion in share repurchases and $600 million in dividends [39] Q&A Session Summary Question: Insights on bookings and pipeline shifts - Management noted that productivity gains from leveraging AI are leading to new deals and opportunities for consolidation, particularly in financial services [43][44] Question: Impact of April slowdown on decision-making - Management indicated that the slowdown is primarily seen in the Products and Resources segment, while Financial Services remains strong [56][57] Question: Comfort level regarding backlog coverage - Management expressed confidence in the backlog coverage, with a book-to-bill ratio of 1.3x and healthy demand in applications, AI, and cybersecurity [76] Question: Gross margin trends and expectations - Management highlighted that cost discipline will drive operating margin outcomes, with utilization and productivity improvements being key factors [78] Question: Sustainability of current growth and market position - Management emphasized the need for consistency in performance and expressed confidence in sustaining growth through a broad-based portfolio and strong market position [85][86]

Financial Data and Key Metrics Changes - First quarter revenue grew by 8.2% year over year in constant currency to $5,100 million, driven by the Belcan acquisition and organic growth in Health Sciences and Financial Services [6][25] - Adjusted Operating Margin improved by 40 basis points year over year to 15.5%, on track to achieve full year guidance of 20 to 40 basis points of expansion [8][32] - Adjusted EPS grew 10% year over year, marking the sixth consecutive quarter of year over year growth [8][25] Business Line Data and Key Metrics Changes - Health Sciences revenue increased over 11% year over year in constant currency, with broad-based growth across payer, provider, and life sciences [7][28] - Financial Services segment grew 6.5% year over year in constant currency, with healthy discretionary spending as clients invested in cloud and data modernization [7][28] - Products and Resources segment growth was driven by Welch, but overall demand environment remained weak due to discretionary spending pressures [29] Market Data and Key Metrics Changes - North America revenue grew 10% year over year in constant currency, driven by Belcan and large deals [30] - Europe revenue increased by 3% year over year in constant currency, supported by life sciences and financial services clients [30] - The Rest of the World saw a 7% year over year increase in constant currency, driven by large deals in Communications, Media, and Technology [31] Company Strategy and Development Direction - The company is investing heavily in AI-powered software-led engineering, integrating expertise in embedded software and IoT with capabilities from recent acquisitions [10][21] - Strategic imperatives include amplifying talent, scaling innovation, and accelerating growth, with a focus on AI and embedded engineering [16][19] - The company aims to build a resilient and durable organization that can thrive in both slow and high-velocity markets [5][9] Management's Comments on Operating Environment and Future Outlook - The macro environment has changed sharply, leading to elevated uncertainty, but the company sees opportunities related to productivity and efficiency [9][26] - Management remains optimistic about the pipeline for large deals and believes the current environment presents opportunities for cost optimization and vendor consolidation [26][39] - The company expects revenue growth of 3.5% to 6% in constant currency for the full year 2025, with adjusted operating margin guidance of 15.5% to 15.7% [36][37] Other Important Information - The company has approximately 1,400 early Gen AI engagements, reflecting a strong focus on AI-led productivity [11][12] - The company plans to establish a 14-acre immersive learning center in Chennai, India, to train 100,000 individuals annually in advanced AI technologies [17][20] - The company returned $364 million of capital to shareholders through share repurchases and dividends during the quarter [35] Q&A Session Summary Question: Shift in bookings and pipeline quality - Management noted that productivity gains from leveraging AI are leading to new deals and opportunities for consolidation, particularly in financial services [42][44] Question: April slowdown in decision-making - Management indicated that while there is some caution in health and products and resources sectors, financial services remain strong, and the impact is seen as isolated [56][57] Question: Organic growth and headcount changes - Management confirmed that organic growth has been driven by healthcare and financial services, with a significant improvement in utilization from 82% to 85% [64][90] Question: Confidence in cost takeout deals - Management expressed confidence that the current environment is conducive for closing cost takeout deals, despite some delays in mega deals [93]